{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:57:38Z","timestamp":1789617458616,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Genentech, Inc"},{"name":"Cancer Epidemiology, Prevention, and Control Training Grant"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-CA-009314"],"award-info":[{"award-number":["T32-CA-009314"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jaad.2019.09.075","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T01:32:22Z","timestamp":1570411942000},"page":"832-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2\u00a0cm or larger in diameter"],"prefix":"10.1016","volume":"83","author":[{"given":"Frederick C.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Stamell","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritesh S.","family":"Karia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Besaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A.","family":"Neel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysalyne D.","family":"Schmults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaad.2019.09.075_bib1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/jamadermatol.2015.1188","article-title":"Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998-2012","volume":"151","author":"Asgari","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.09.075_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.09.075_bib3","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jaad.2019.09.075_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Work Group","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.09.075_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4725.1989.tb03166.x","article-title":"Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2019.09.075_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.2004.06047.x","article-title":"Mohs' micrographic surgery for treatment of basal cell carcinoma of the face\u2014results of a retrospective study and review of the literature","volume":"151","author":"Smeets","year":"2004","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.09.075_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(08)70260-2","article-title":"Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years\u2019 follow-up","volume":"9","author":"Mosterd","year":"2008","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2019.09.075_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1524-4725.1992.tb03307.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision","volume":"18","author":"Silverman","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2019.09.075_bib9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","article-title":"Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature","volume":"10","author":"von Domarus","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.09.075_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/1097-0142(19940115)73:2<328::AID-CNCR2820730216>3.0.CO;2-U","article-title":"Metastatic basal cell carcinoma. Report of five cases","volume":"73","author":"Snow","year":"1994","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jaad.2019.09.075_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1524-4725.1991.tb03424.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 1: overview","volume":"17","author":"Silverman","year":"1991","journal-title":"J Dermatol Surg Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2019.09.075_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.6004\/jnccn.2016.0065","article-title":"Basal cell skin cancer, version 1.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Bichakjian","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.jaad.2019.09.075_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaad.2005.04.089","article-title":"Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion","volume":"53","author":"Leibovitch","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.09.075_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archderm.1983.01650290013008","article-title":"Multivariate risk score for recurrence of cutaneous basal cell carcinomas","volume":"119","author":"Dubin","year":"1983","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.09.075_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1524-4725.1981.tb00171.x","article-title":"Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score","volume":"7","author":"Rigel","year":"1981","journal-title":"J Dermatol Surg Oncol"},{"issue":"5 Pt 2","key":"10.1016\/j.jaad.2019.09.075_bib16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0190-9622(94)70098-2","article-title":"Giant basal cell carcinoma. Report of two cases and review of the literature","volume":"30","author":"Sahl","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.09.075_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-4362.1980.tb00281.x","article-title":"Why does basal cell carcinoma metastasize so rarely?","volume":"19","author":"Blewitt","year":"1980","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.09.075_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamadermatol.2013.3064","article-title":"Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011","volume":"149","author":"Wysong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.09.075_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1470-2045(15)70198-1","article-title":"Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial","volume":"16","author":"Basset-Seguin","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219328245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219328245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:56:07Z","timestamp":1759272967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219328245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0190962219328245"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.09.075","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2\u00a0cm or larger in diameter","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.09.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}